Literature DB >> 31424309

ARID5B rs10821936 and rs10994982 gene polymorphisms and acute lymphoblastic leukemia: relation to disease susceptibility and outcome.

Youssef M Mosaad1, Mohamed Khashaba2, Ahmad Darwish3, Mohamed Darwish1, Mona Elwassefy1, Souzy Abdelmabood3, Iman M Fawzy4, Laila F Youssef5, Rehab A Elbasiouny6.   

Abstract

ARID5B rs10821936 and rs10994982 single nucleotide polymorphism (SNP) have been associated with the risk of acute lymphoblastic leukemia (ALL) in different ethnic populations. We investigated the association between the ARID5B rs10821936 C > T, rs10994982 A > G, and susceptibility to ALL in a cohort of Egyptian individuals and investigated their role in relation to disease outcome. Real-time PCR typing was done for ARID5B rs10821936 and rs10994982 SNPs for 128 pediatric ALL (pALL), 45 adult ALL (aALL), and 436 healthy controls. Significant risk associations were found between the C allele (p < 0.001, OR = 2.02), CC genotype (p < 0.001, OR = 2.72), CT genotype (p = 0.011, OR = 1.45) of ARID5B rs10821936 and pediatric ALL especially T-ALL and adult ALL (p < 0.05). The CA haplotype (C allele of rs10821936 + A allele of rs10994982) was associated with the risk of ALL either pediatric ALL or adult ALL (p < 0.001). In the studied Egyptian population, it can be concluded that the C allele, CC, and CT genotypes of ARID5B rs10821936 and the CA haplotype may be a susceptibility risk factor for pediatric and adult ALL. However, the SNPs of ARID5B rs10821936 and rs10994982 were not found to be strongly associated with ALL outcomes.

Entities:  

Keywords:  ALL; ARDIB5 rs10821936; ARID5B rs10994982; Egyptian; RT-PCR; SNPs

Mesh:

Substances:

Year:  2019        PMID: 31424309     DOI: 10.1080/08880018.2019.1649333

Source DB:  PubMed          Journal:  Pediatr Hematol Oncol        ISSN: 0888-0018            Impact factor:   1.969


  1 in total

1.  Genetic Variants in METTL14 are Associated with the Risk of Acute Lymphoblastic Leukemia in Southern Chinese Children: A Five-Center Case-Control Study.

Authors:  Ailing Luo; Lihua Yang; Ming Li; Mansi Cai; Amin Huang; Xiaodan Liu; Xu Yang; Yaping Yan; Xueliang Wang; Xuedong Wu; Ke Huang; Libin Huang; Shanshan Liu; Ling Xu; Xiaoping Liu
Journal:  Cancer Manag Res       Date:  2021-12-14       Impact factor: 3.989

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.